Chronic infections and coronary heart disease: Is there a link?

Lancet

Volumn 350, Issue 9075, 1997, Pages 430-436

  Danesh, John ^a   Collins, Rory ^a   Peto, Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0030757024     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)03079-1     Document Type: Review

References (62)

1. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148: 335-40.
2. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67: 1123-37.
3. Peto R. Two properties of multiple regression analysis; and regression to the mean (and regression from the mean). In: Fletcher CM, Peto R, Tinker CM, Speizer FE, eds. The natural history of chronic bronchitis and emphysema: an eight year study of early chronic obstructive lung disease in working men in London. Oxford: Oxford University Press, 1976: 218-23.
4. Gill EA, McIntyre TM, Prescott SM, Zimmerman GA. Mechanisms of vascular injury in the pathogenesis of infectious disease. Curr Opin Infect Dis 1992; 5: 381-88.
5. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997; 349: 1391-92.
6. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993; 14: (suppl K): 57-61.
7. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1996; 348 (suppl I): s13-17.
8. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-14. (Erratum BMJ 1995; 311: 985.)
9. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-65.
10. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-79.
11. Birnie D, McKay IC, Hood S, McColl KEJ, Hillis WS. Association between antibodies to mycobacterial heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of Helicobacter pylori in increasing cardiovascular risk. Heart 1996; 75 (suppl 1): p64 (abstr).
12. Niemela S, Karttunen T, Korhonen T, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996; 75: 573-75.
13. Scragg RKR, Fraser A, Metcalf PA. Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidemiol Commun Health 1996; 50: 578-79.
14. Sung JJY, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart 1996; 76: 305-07.
15. Mendall MA, Goggin PM, Molineaux N, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-97.
16. Colin-Jones DG, Langman MJS, Lawson DH. Postmarketing surveillance of the safety of cimetidine: 10 year mortality report. Gut 1992; 33: 1280-84.
17. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74: 497-501.
18. Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 1996; 2: 372-79.
19. Ndawula EM, Owen RJ, Mihr G, Borman P, Hurtado A. Helicobacter pylori bacteraemia. Eur J Microbiol Infect Dis 1994; 13: 621.
20. Gonzalez-Valencia G, Perez-Perez GI, Washburn RG, Blaser MJ. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter 1996; 1: 1-6.
21. Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996; 34: 2766-69.
22. Wang SP, Grayston JT. Microimmunofluorescence serology in Chlamydia trachomatis. In: de la Maza LM, ed. The 1983 International Symposium on Medical Virology, New York: Elsevier Science, 1984: 87-118.
23. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immunity 1996; 64: 1614-20.
24. Campbell LA, Moazed TC, Kuo CC, Grayston JT. Mouse models of atherosclerosis and Chlamydia pneumoniae. Proc Third Eur Soc Chlam Res 1996; 3: 106(abst).
25. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158-61.
26. Kuo C, Shor A, Campbell L, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-49.
27. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13: 1501-04.
28. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92: 6911-14.
29. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585-88.
30. Grayston JT, Kuo CC, Coulson AS, et al. Chalmydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-400.
31. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996; 173: 957-63.
32. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27: 1555-61.
33. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102-06.
34. Cunningham A, Matthews R, Ellis R, Ward ME. Direct demonstration of Chlamydia pneumoniae and Helicobacter pylori in coronary heart disease. Proc Third Eur Soc Chlam Res 1996; 3: 106(abstr).
35. Ong G, Thomas B, Mansfield AO, et al. Chlamydia pneumoniae in vascular tissue. Proc Third Eur Soc Chlam Res 1996; 3: 222 (abstr).
36. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993; 31: 2212-14.
37. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996; 125: 979-82.
38. Juvonen J, Laurila A, Juvonen T, et al. Detection of Chlamydia pneumoniae in human non-rheumatic stenotic aortic valves. Proc Third Eur Soc Chlam Res 1996; 3: 221 (abstr).
39. Kaner RJ, Hajjar DP. Viral activation of thrombo-atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996: 569-84.
40. Nieto FJ, Adam E, Sorlie P, et al. A cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94: 922-27.
41. Larsson PA, Edstrom S, Westin T, Nordkvist A, Hirsch JM, Vahlne A. Reactivity against herpes simplex virus in patients with head and neck cancer. Int J Cancer 1991; 49: 14-18.
42. Havlik RJ, Blackwelder WC, Kaslow R, Castelli W. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. Arteriosclerosis 1989; 9: 877-80.
43. Benditt EP, Barrett T, McDougall JK. Viruses in the aetiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80: 6386-89.
44. Melnick JL, Dreesman GR, McCollum CH, Petrie BL, Burek J, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983 ii: 644-47.
45. Gyorkey F, Melnick JL, Guinn GA, Gyorkey P, DeBakey ME. Herpesvirus in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients. Exp Mol Pathol 1984; 40: 328-39.
46. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988; 130: 71-79.
47. Hendrix MGR, Dromans PHJ, Kitslaar P, Bosman F, Bruggeman CA. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 1989; 134: 1151-57.
48. Hendrix MGR, Salimns MMM, van Boven CPA, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23-28.
49. Hendrix MGR, Daemen M, Bruggeman CA. Cytomegalovirus nucleic acid distribution with the human vascular tree. Am J Pathol 1991; 138: 563-67.
50. Wu TC, Hruban RH, Ambinder RF, et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 1992; 140: 739-47.
51. Melnick JL, Hu CH, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994; 42: 170-74.
52. Fernando S, Booth J, Boriskin Y, et al. Association of cytomegalovirus infection with post-transplantation cardiac rejection as studied using the polymerase chain reaction. J Med Virol 1994; 42: 396-404.
53. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-94.
54. Guilizia JM, Kandolf R, Kendall TJ, et al. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995; 147: 461-75.
55. Petrie BL, Melnick JL, Adam E, Burek J, McCollum CH, DeBakey ME. Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis 1987; 155: 158-59.
56. Pauletto P, Pisoni G, Boschetto R, Zoleo M, Pessina AC, Palu G. Human cytomegalovirus and restenosis of the internal carotid artery. Stroke 1996; 27: 1669-71.
57. Chen R, Wu L, Yang Y. Detection of HCMV DNA in vascular plaques of atherosclerosis by in situ hybridisation. Natl Med J China 1995; 75: 592-94.
58. Petrie BL, Adam E, Melnick JL. Association of herpesvirus/cytomegalovirus infections with human atherosclerosis. Prog Med Virol 1988; 35: 21-42.
59. Bruggeman CA, van Dam-Mieras MCE. The possible role of cytomegalovirus in atherogenesis. In: Melnick JL, ed. Prog Med Virol. Basel: Karger, 1991: 1-26.
60. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70: 1753-56.
61. Kol A, Sperti G, Shani J, et al. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995; 91: 1910-13.
62. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori: genetic and environmental influences: a study of twins. Ann Intern Med 1994; 120: 982-86.